Todos os estudos
Ainda não recrutandoOBSERVACIONAL

Vascular Health and Function in Cystic Fibrosis

Thanks to modern medicines called CFTR modulators, people with cystic fibrosis (CF) are living longer, fuller lives. Because of this welcome change, doctors want to understand how growing older with CF affects the heart, blood vessels, and brain. This study compares the blood vessel health of adults with CF aged 40 and older with healthy adults of the same age and sex. Researchers want to see if blood vessels work differently in people with CF and whether this affects brain blood flow, memory, or mood. Taking part involves a single visit lasting around two and a half to three hours at a hospital in Liverpool or a university clinic in Manchester. Participants will have simple, painless ultrasound scans, basic heart and breathing checks, a routine blood test, and short memory puzzles. No new medications are tested, and taking part will not change your normal healthcare.

Em resumo

Status
Ainda não recrutando
Patrocinador
Fundação NHS do Hospital Cardíaco e Torácico de Liverpool
Meta de inscrição
100
Iniciar
10 Oct 2026
Conclusão estimada
01 Jul 2030

Sobre o que é este estudo?

In recent years, modern treatments known as CFTR modulators have transformed life for people with cystic fibrosis (CF). Because people are living longer into adulthood, doctors are now turning their attention to conditions that tend to appear as we age, including heart and blood vessel problems.

This observational study aims to explore how CF affects the body's circulation. Researchers want to compare blood vessel health between people with CF who are 40 or older and healthy volunteers of a similar age. They will look closely at how well the arteries in your arm and neck expand and contract, and how smoothly blood travels up to the brain during daily activities like standing up.

The research team will also check blood samples for signs of inflammation (the body's natural response to irritation or infection) and stress in the cells. In addition, they will look at whether blood vessel health is linked to day-to-day well-being, mood, and memory.

Because this is an observational study, you will not be asked to try any new medicines or change your existing care. The information gathered will help doctors understand cardiovascular health in people with CF, paving the way for better long-term care and advice in the future.

Pontos principais

  • The study explores how cystic fibrosis affects blood vessels, heart health, and brain circulation in adults aged 40 and older.
  • It compares adults with CF who take CFTR modulators against healthy volunteers of the same age and sex.
  • Participation involves just one visit lasting approximately 2.5 to 3 hours at a clinic in Liverpool or Manchester.
  • Assessments include non-invasive ultrasound scans, breathing checks, a blood test, and brief memory tasks.
  • No new medicines are being tested, and taking part will not disrupt your usual daily care.

Quem pode ser elegível?

This study is open to men and women aged 40 and older who fall into one of two groups. The first group includes people with a confirmed diagnosis of cystic fibrosis who are taking CFTR modulator therapy and have been in stable health for at least four weeks (with no chest flare-ups or hospital stays). The second group includes healthy volunteers of a similar age and sex who do not take regular prescription medicines, apart from HRT or contraception.

To keep tests safe and results reliable, certain people cannot take part. You cannot join if you have had a stroke, a heart attack in the last three months, heart valve problems, an organ transplant, active cancer, or an uncontrolled thyroid condition. People with long-term inflammatory conditions, such as rheumatoid arthritis or lupus, are also excluded.

Additionally, you cannot take part if you currently smoke or vape, or if you have smoked or vaped within the last ten years. The study is also not suitable for anyone who is pregnant, breastfeeding, taking regular steroid tablets or blood vessel medications, or has high blood pressure at the clinic visit.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. Are you 40 years of age or older?
  2. Do you have cystic fibrosis and take a CFTR modulator, OR are you in good health and take no regular prescription medicines?
  3. Have you been free from chest infections or hospital stays for at least the last 4 weeks?
  4. Have you been completely smoke-free and vape-free for the past 10 years?
  5. Are you free from a history of stroke, recent heart problems, or organ transplants?
  6. Are you able to attend a single 3-hour visit in Liverpool or Manchester?
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

Taking part involves a single visit lasting about two and a half to three hours. This visit takes place at Liverpool Heart and Chest Hospital, though some healthy volunteers may attend Manchester Metropolitan University instead. There are no follow-up visits or home tasks once your appointment is finished.

During the visit, researchers will: • Measure your height, weight, waist, and body fat percentage. • Take a routine blood sample to check general health, cholesterol, and inflammation markers. • Perform painless ultrasound scans on the arteries in your arm and neck. This includes wearing a snug blood pressure cuff on your wrist for five minutes and resting your hand in cool water for three minutes. • Monitor your heart rhythm, blood pressure, and breathing while you rest, stand up, do a few gentle squats, and open or close your eyes. • Ask you to complete brief memory puzzles and short questionnaires about your mood and quality of life.

You will not be given any experimental medicines, and your normal treatment plan will not change.

Riscos e benefícios potenciais

You will not receive any direct medical treatment or personal health benefits from taking part. However, your participation will help doctors better understand how to protect heart and brain health in people ageing with cystic fibrosis. The assessments carry very low risk. You might feel slight, brief discomfort from the blood test needle, the tightness of the wrist cuff, or resting your hand in cool water. The squatting exercise is gentle, but you can rest if you feel tired or lightheaded. Taking part is entirely voluntary, and you are free to stop the tests or leave the study at any time without it affecting your standard medical care.

Localizações (1)

  • Fundação NHS do Hospital Cardíaco e Torácico de Liverpool
    Código postal verificado
    Liverpool, Reino Unido

Perguntas frequentes

Will taking part change my usual cystic fibrosis treatments?

No. You will continue to take your regular CFTR modulators and other prescribed medicines as normal. The study does not test any new treatments.

Do any of the tests hurt?

Most tests are completely painless. You may feel a brief pinch during the routine blood test, some pressure when the wrist cuff is inflated, or mild coolness when your hand is placed in cool water.

How many appointments do I need to attend?

You only need to attend one single appointment. It will last roughly two and a half to three hours.

What if I feel unwell or have a chest infection before my visit?

You must be clinically stable with no chest flare-ups or hospital stays for at least four weeks before your visit. If you become unwell, let the team know so they can reschedule your appointment for when you are fully recovered.

Posso sair do estudo se mudar de ideia?

Yes. You can withdraw from the study at any point, even during the visit, without giving a reason. Your standard NHS care will not be affected in any way.

Como saber mais

Freddy Frost

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Interessado em participar?

Registre seu interesse

Compartilhe seus detalhes e a equipe de pesquisa para "Vascular Health and Function in Cystic Fibrosis…" entrará em contato com você se você for elegível. Sempre fale com seu médico antes de concordar em participar.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.